According to Hims & Hers Health's latest financial reports the company's current earnings are $1.78 Billion USD. In 2024 the company made an earning of $71.71 Million USD, an increase over its 2023 earnings that were of -$21.58 Million USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | $0.11 B | 67.06% |
2024 | $71.71 M | -432.44% |
2023 | -$21.58 Million | -67.17% |
2022 | -$65.71 Million | -40.69% |
2021 | -$0.12 Billion | 515.97% |
2020 | -$17.99 Million |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Novocure
NVCR | -$0.12 Billion | -197.80% | Jersey |
![]() Novavax NVAX | $0.51 B | 325.87% | ๐บ๐ธ USA |
![]() Organovo ONVO | -$12.39 Million | -110.34% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | -$73.07 Million | -160.98% | ๐ฌ๐ง UK |